Tranche Update on IQVIA Holdings Inc.'s Equity Buyback Plan announced on October 31, 2013.
July 27, 2021 at 07:06 am EDT
Share
From April 1, 2021 to June 30, 2021, the company has repurchased 193,500 shares, representing 0.1% for $45.01 million. With this, the company has completed the repurchase of 67,057,808 shares, representing 39.08% for $6,176.83 million under the buyback announced on October 31, 2013.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
IQVIA HOLDINGS INC. 
